Steve Hong – CEO; Tony Lim – COO & Vice President, Lemon Healthcare,…
Steve Hong, CEO, and Tony Lim, vice president & COO of Lemon Healthcare, lift the lid on the new streamlined hospital data services they are offering, and the benefits to…
One of the leading pharmaceutical companies in Korea, has created its own history: Boryung Pharm., as a parent company of Boryung Pharmaceutical Group, has been founded in 1963 after opening Boryung Pharmacy in 1957, and solidified its leadership position as a herb medicine manufacturer. From the year 1967 with Yongkaksan, Kushim, Gelfos and Kiungwhan, the legend recognized by all people have been created. Lately by developing and exporting new drugs such as Doxorubicin HCl and Fimasartan which are developed by our own technology, Boryung Pharm. is playing a major role as a principal axis power in the globalization of Boryung Pharmaceutical Group. Boryung Pharm., one of the 10 best pharmaceutical companies in Korea, is contributing to human health by manufacturing and launching on the market with 300 ethical products and 60 OTC products based on the initiative of Boryung R&D Institute.
Steve Hong, CEO, and Tony Lim, vice president & COO of Lemon Healthcare, lift the lid on the new streamlined hospital data services they are offering, and the benefits to…
The French-Korean Chamber of Commerce and Industry (FKCCI) has grown rapidly in the last decade, both in terms of members and revenues. Its managing director, Stella Yoon, explains how the…
YongBum Choi, general manager of Ferring Korea, explains how he plans to foster the Ferring values in the local affiliate. Mr Choi also breaks down the stigmas associated with assisted…
The Pharmaceutical Strategy Institute (PSI) is a Korean consulting firm helping local biotech companies reach success by providing strategic and legal counsel all along the value chain. Its founder &…
James Jungkue Lee, founder and CEO of Bridge Biotherapeutics, explains his strategy for risk mitigation in running a virtual biotech start-up. He also offers his insights into the company’s partnership…
Dr Jin Hyoung Kang, president of the Cancer Study Group comments on the scope for oncology drug development in Korea, and the issues resulting from the structure of Korea’s healthcare…
Quegen Biotech is a company focusing on manufacturing beta-glucan for use in a range of healthcare products, from hangover cures to oncology treatments. In this interview, Dr Jong Dae Lee…
Pil Soo Oh has been the managing director of Lundbeck Korea since the establishment of the affiliate in 2002. Mr Oh offers his insights into Lundbeck’s footprint in Korea, their…
Jong-Gu Chung, general manager of CooperVision Korea, lifts the lid on his strategy to establish their position in the Korean market for contact lenses. Chung also gives his assessment of…
Established in 1986, the KDRA is Korea’s leading new drug research and development special corporation, established under the Ministry of Science and ICT and composed of 350 members. Its executive…
LG Life Sciences is one the early pioneers of innovative drug development in Korea with a diversified portfolio of chemical drugs, vaccines, biosimilars, biologics, and dermo-cosmetics. Its president, Dr Son,…
South Korean heavyweight Daewoong Pharmaceutical saw record sales in 2018, but did see a decrease in its EBITDA figures. To ensure its future profitability, the company has decided to invest…
See our Cookie Privacy Policy Here
